Study to Evaluate the Efficacy of a Doctor-led Digital Diabetes Program Aided by a Data-driven Coaching Intervention Process in Achieving Better Glycemic Control in Uncontrolled Type II Diabetics - Not applicable

Curo Healthcare0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•Type II Diabetes Mellitus subjects of either sex aged 18 to 65years.
•HbA1c value greater than 7.0%.
•Subjects able to provide written informed consent.
•Subjects using android mobile.
•Agree to follow Keto/T2DM diet and use Keto calculator app.
•If female of childbearing age, willing to use an acceptable form of birth control measure, should be stable for past 3 months prior to baseline and throughout the study.

•Subjects with deteriorating health status at the time of enrolment; rapid weight loss, terminal disease, significant chronic disease (e.g., chronic diarrhoea, gastro-intestinal disease, irritable bowel syndrome).
•Recent blood donation (within 3 months from the date of screening).
•Immunodeficiency disease (e.g., human immunodeficiency virus [HIV] infection).
•Pregnant or breast feeding women.
•Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study.
•Conditions in the opinion of the investigator make the patient unsuitable to participate in the study.
•Any contraindication to blood sampling.

发起方

Curo Healthcare